Research Article
Clinical Manifestations Associated with Overweight/Obesity in Puerto Ricans with Fibromyalgia Syndrome
Table 3
Comorbidities in nonoverweight/obese and overweight/obese patients with fibromyalgia syndrome.
| Comorbidity | Nonoverweight/obese BMI ≤ 24.9 | Overweight/obese BMI ≥ 25 | value | () | () | % | % |
| Osteoarthritis | 48.6 | 62.4 | 0.148 | Cervical spine disease | 34.3 | 27.5 | 0.444 | Lumbar spine disease | 31.4 | 42.2 | 0.257 | Osteoporosis | 11.4 | 8.26 | 0.391 | Peripheral neuropathy | 17.4 | 20.2 | 0.693 | Hyperthyroidism | 0.0 | 0.92 | 0.757 | Hypothyroidism | 11.4 | 14.7 | 0.434 | Hypertension | 28.6 | 37.6 | 0.330 | Hyperlipidemia | 40.0 | 44.0 | 0.675 | Type 2 diabetes mellitus | 0.0 | 12.8 | 0.016 | Coronary artery disease | 0.0 | 1.8 | 0.572 | Stroke | 0.0 | 1.8 | 0.572 | Bronchial asthma | 11.4 | 16.5 | 0.334 | Chronic obstructive pulmonary disease | 0.0 | 0.9 | 0.757 | Anemia | 2.9 | 8.3 | 0.250 | Malignancy | 0.0 | 3.7 | 0.321 |
|
|